I earned my PhD from the University of Queensland in 2019 under the supervision of Prof. David Craik, where I conducted research centred around developing highly selective and potent peptides targeting specific ion channels or receptors. Following my doctoral studies, I joined Prof. Kenton Swartz'd group at the esteemed National Institutes of Health (USA) as a postdoctoral researcher. During my time there, my research primarily revolved around investigating the inactivation mechanism of potassium channels and its relevance to various diseases. After dedicating three years to my work at the NIH, I returned to the University of Queensland towards the end of 2022 and joined Assoc Prof. Richard Clark's group. Currently, my research endeavours encompass the design of peptides endowed with enhanced stability and prolonged in vivo half-lives. This pursuit aims to advance our understanding of peptide-based therapeutics, focusing on their potential for practical clinical applications.